Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


J&J/McNeil Completes Remediation Under Consent Decree

This article was originally published in The Tan Sheet

Executive Summary

FDA officials on Aug. 21 notified the firm that its Fort Washington, Pa., manufacturing plant is compliant with the agency’s GMP regulations for drugs.


Related Content

Nicorette, Tylenol Ease J&J's Consumer Pain From Slow Oral Care Sales
J&J Settlement With States Not Likely To Be Precedent In OTC Space
J&J Invests In Consumer Business For Long Haul, Not Quick Sale
Missing CAPA Costs J&J $25 Million In Investigation Sparked By OTC Recalls


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts